Image

Detection of single nucleotide variants in circulating tumor DNA of patients with metastatic castration resistant prostate cancer

Study of Cell-Free DNA in Prostate Cancer

Recruiting
100 years and younger
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates cell-free DNA in patients with metastatic castration-resistant prostate cancer. Metastatic castration-resistant prostate cancer is a type of prostate cancer that continues to grow and spread even when the amount of testosterone in the body is reduced to very low levels. The study aims to understand how cell-free DNA, which are small pieces of DNA found in the blood, can be used to track the cancer's response to treatment.

Participants will receive therapy with either an investigational medication or a placebo. The study will involve regular blood tests to measure cell-free DNA levels. A placebo is an inactive substance that looks like the investigational medicine but does not contain any medicine.

  • Who can participate: Men aged 18 and older with metastatic castration-resistant prostate cancer who are eligible for treatment with abiraterone or enzalutamide may participate.
  • Study details: Participants will be assigned to receive either an investigational medication or a placebo. Blood samples will be collected to measure cell-free DNA levels. A placebo is an inactive substance that looks like the investigational medicine but does not contain any medicine.
Print
Study details
    prostate cancer

TX7906

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.